It’s getting better: AIDS Map’s Roger Pebody wrote about findings from here in BC that show that among the populations of people with HCV, an analysis found that older people, those co-infected with HIV, those who have cirrhosis and those who use drugs are more likely to receive direct-acting antiviral HCV treatment than was the case with older treatment options.
CATIE’s Sean Hosein titled a piece, Is this the end for HCV drug development? Sean writes about the success of current and soon-to-be-available treatments that boast a 95% cure rate. With this type of treatment, why work on newer drugs?
Pharmaceutical company Gilead has received approval in Canada for expanded indication of treatment for chronic Hepatitis C in people who are co-infected with HIV. This one pill a day option is said to be compatible with most HIV treatment drugs, although there are some considerations.
CATIE has posted a link to the latest Report on Hepatitis B and C in Canada.
BC Centre for Excellence Videos
These two videos are from the Spring 2017 HIV/Antiretroviral Update
Updates to therapy to treat HCV (Alnoor Ramji)
Hepatitis C Virus Testing: Update and Recommendations (Lianping Ti)
Community Connections: Help4HepBC
Questions? Feedback? Get in touch! Janet Madsen, Capacity Building and Knowledge Translation Coordinator, [email protected]